| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-06 |
| filingDate |
2005-06-23^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8127aae89225ba512692b270e73c50d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b73ef33a1f246a4049f069100961ab96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c15e9b8b5f44d1f23eba096d1017c07 |
| publicationDate |
2007-03-09^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20070027656-A |
| titleOfInvention |
Quinoline thiazolinone with CDD1 antiproliferative activity |
| abstract |
The present invention provides the following novel thiazolinone disubstituted quinoline derivatives having a quinoline ring substituted at positions 3 and 4, which are useful as anticancer agents because they exhibit CDK1 antiproliferative activity:n n n . |
| priorityDate |
2004-07-01^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |